Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Real-World Effectiveness and Safety of Eltrombopag in Patients with Aplastic Anemia: A Chinese Nationwide Survey

Wenrui Yang, MD, Bing Han, MD PhD, Hong Chang, MD, Bingyi Wu, MD, Fankai Meng, Dexiang Ji, MD, Yingmei Li, MD, Zhengjin Zheng, MD, Yan Fei, Jianping Shen, MD, Ping Hu, MD, Jianxiang Wang, MD, Fengkui Zhang, MD

Blood (2019) 134 (Supplement_1): 5020.

https://doi.org/10.1182/blood-2019-126441

Published: 2019

Journal Articles

Downregulation of MDM2 Leads to Anti-Proliferative Effects through Activation of p53-Associated Pathway Mediated By Both Dual Inhibitor MX69 and Mir-548c-3p in Multiple Myeloma

Faruq Faruq, PhD, Davidson Zhao, Jian Wu, MD, Jonahunnatha Nesson George William, PhD, Min Zhang, MD, Hong Chang, MD

Blood (2019) 134 (Supplement_1): 4419.

https://doi.org/10.1182/blood-2019-129430

Published: 2019

Journal Articles

Efficacy Analysis of Ruxolitinib in Treatment of 72 Patients with Myelofibrosis in a Chinese Institution

Yunfan Yang, MD, Zhongqing Zou, MD, Ting Liu, MD PhD, Yongqian Jia, PhD, Ting Niu, MD PhD, Huanling Zhu, MD, Yu Wu, MD, Yuping Gong, MD, Hong Chang, MD, Jie Ji, MD, Jian Li, MD, Ling Pan

Blood (2019) 134 (Supplement_1): 5384.

https://doi.org/10.1182/blood-2019-128553

Published: 2019

Journal Articles

Overexpression of Mir-21-5p Induces Apoptosis and Cell Cycle Arrest By Down-Regulating SKP2 and Overcomes Bortezomib Resistance in Multiple Myeloma

Jonahunnatha Nesson George William, PhD, Jian Wu, MD, Ziyan Chen, Omar Faruq, PhD, Hong Chang, MD

Blood (2019) 134 (Supplement_1): 1823.

https://doi.org/10.1182/blood-2019-128917

Published: 2019

Journal Articles

Targeting CD47 and TNFAIP8 By Mir-155 Overcomes Drug Resistance and Inhibits Tumor Growth through Induction of Phagocytosis and Apoptosis in Multiple Myeloma

Nasrin Rastgoo, PhD, Jahangir Abdi, PhD, Maryam Pourabdollah, MD, Hong Chang, MD

Blood (2018) 132 (Supplement 1): 1923.

https://doi.org/10.1182/blood-2018-99-113057

Published: 2018

Journal Articles

Marcks Inhibition By a Peptide Inhibitor, MPS, Cooperates with Bortezomib to Effectively Eliminate Drug Resistance in Multiple Myeloma

Lun Zhang, Nasrin Rastgoo, PhD, Maryam Pourabdollah, MD, Eldad Zacksenhaus, PhD, Yan Chen, MD PhD, Guoan Chen, MD, Hong Chang, MD

Blood (2018) 132 (Supplement 1): 1936.

https://doi.org/10.1182/blood-2018-99-113026

Published: 2018

Journal Articles

Targeting of Marcks By MiR-34a Overcomes Drug Resistance in Multiple Myeloma

Nasrin Rastgoo, PhD, Yan Chen, MD PhD, Jahangir Abdi, PhD, Minjing Wang, Chen Guoan, MD, Hong Chang, MD

Blood (2017) 130 (Supplement 1): 4377.

https://doi.org/10.1182/blood.V130.Suppl_1.4377.4377

Published: 2017

Journal Articles

Inhibition of the Epigenetic Modifier EZH2 By Mir-138 Upregulates Tumor Suppressor Gene Rbpms and Contributes to Drug Susceptibility in Preclinical Model of Multiple Myeloma

Nasrin Rastgoo, PhD, Maryam Pourabdollah, MD, Jahangir Abdi, PhD BSc, MSc, Hong Chang, MD

Blood (2017) 130 (Supplement 1): 269.

https://doi.org/10.1182/blood.V130.Suppl_1.269.269

Published: 2017

Journal Articles

Restoration of Mir-138 Expression By Epigenetic Modulation Overcomes Drug Resistance in Multiple Myeloma Cells

Nasrin Rastgoo, PhD, Jahangir Abdi, PhD, Lun Zhang, PhD, Minjing Wang, Hong Chang, MD PhD

Blood (2016) 128 (22): 2060.

https://doi.org/10.1182/blood.V128.22.2060.2060

Published: 2016

Journal Articles

Marcks Peptide Inhibitor Displays Synergistic Cytotoxicity with Bortezomib in Drug Resistant Multiple Myeloma Cells but Enhances Autophagic Effect

Lun Zhang, PhD, Jahangir Abdi, PhD, Minjing Wang, Nasrin Rastgoo, PhD, Hong Chang, MD PhD

Blood (2016) 128 (22): 2061.

https://doi.org/10.1182/blood.V128.22.2061.2061

Published: 2016

Journal Articles

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

Blood (2016) 128 (22): 4882.

https://doi.org/10.1182/blood.V128.22.4882.4882

Published: 2016

Journal Articles

IKZF1/3 Protein Expressions Are Associated with a Better Survival in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide

Maryam Pourabdollah, MD, Mohammad Bahmanyar, MD, Eshetu G Atenafu, MSc, PStat, Donna Reece, MD, Hong Chang, MD PhD

Blood (2016) 128 (22): 4506.

https://doi.org/10.1182/blood.V128.22.4506.4506

Published: 2016

Journal Articles

Prima-1 Met Combined with Bortezomib Has Synergistic Anti-Myeloma Activity By Modulation of Apoptosis and Cell Cycle Regulating Genes

Priya Khoral, Robert J Guo, Jahangir Abdi, PhD, Hong Chang, MD PhD

Blood (2015) 126 (23): 4213.

https://doi.org/10.1182/blood.V126.23.4213.4213

Published: 2015

Journal Articles

Bone Marrow Stromal Cells Induce Bortezomib Resistance in Multiple Myeloma Cells through Downregulation of miRNA-101-3p Targeting Survivin

Jahangir Abdi, PhD, Yijun Yang, PhD, Patrick Meyer-Erlach, Hong Chang, MD PhD

Blood (2015) 126 (23): 1772.

https://doi.org/10.1182/blood.V126.23.1772.1772

Published: 2015

Journal Articles

Decitabine Combined With Chemotherapy For The Treatment Of Refractory Acute Myeloid Leukemia: a Pilot Phase 1 Clinical Study

Ling Pan, MD, PhD, Meng Chen, Yongqian Jia, MD, PhD, Xu Cui, MD, Ting Niu, MD, PhD, Hong Chang, MD, PhD, Hongbing Ma, MD, Jianjun Li, MD, Yuping Gong, MD, PhD, Xinchuan Chen, MD, Ting Liu, MD, PhD

Blood (2013) 122 (21): 5001.

https://doi.org/10.1182/blood.V122.21.5001.5001

Published: 2013

Journal Articles

Combination Imatinib with Interferon-α For Philadelphia Positive Acute Lymphocytic Leukemia: A Mutiple Centers Study In China

Pu Kuang, MD, PhD, Yu Wu, MD, PhD, Bing Xiang, MD, Hongbing Ma, MD, Hong Chang, MD, Ting Niu, MD, PhD, Xu Cui, MD, Chuan He, MD, Jianjun Li, MD, Jie Ji, MD, Jie Huang, MD, Tian Dong, MD, PhD, Qing Shenglan, MB, Huaxin Wu, MB, Xiaogong Liang, MSc, Haiying Guo, MB, Chunnong Wu, MB, Ting Liu, MD

Blood (2013) 122 (21): 5019.

https://doi.org/10.1182/blood.V122.21.5019.5019

Published: 2013

Journal Articles

Imatinib 400mg Daily Combined with Vindesine and Dexamethasone As Induction and Maintenance Therapy for Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Ting Liu, MD, Pu Kuang, MD, Tian Dong, MD, Bing Xiang, MD, Jianjun Li, MD, Xinchuan Chen, MD, Chuan He, MD, Hongbing Ma, MD, Jie Ji, MD, Yuping Gong, MD, PhD, Hong Chang, MD, Yu Wu, MD, PhD, Huanling Zhu, MD, Yuchun Wang, MD, PhD

Blood (2011) 118 (21): 4243.

https://doi.org/10.1182/blood.V118.21.4243.4243

Published: 2011

Journal Articles

Experience with Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Study of 56 Patients in a Single Institute of China

Xiao Shuai, MD, Ting Liu, MD, Ting Niu, MD, Hong Chang, MD, Jianjun Li, MD, Jie Huang, MD, Xu Cui, MD, Jie Ji, MD, Hongbing Ma, MD, Bing Xiang, MD, Chuan He, MD, Yu Wu, MD, PhD, Yuping Gong, MD, PhD

Blood (2011) 118 (21): 4727.

https://doi.org/10.1182/blood.V118.21.4727.4727

Published: 2011

Journal Articles

Association of Interferon-Gamma +874(T/A) Single Nucleotide Polymorphism with Response to Immunosuppressive Therapy In Patients with Severe Aplastic Anemia.

Hong Chang, MD, Jia-You Zhang, MD, Xiao-Yan Mu, MD, Wen-Tong Meng, MD, Ting Liu, MD

Blood (2010) 116 (21): 1157.

https://doi.org/10.1182/blood.V116.21.1157.1157

Published: 2010

Journal Articles

Natural Killer (NK) or NK/T Cell Lineage Large Granular Lymphocytosis Associated with Dasatinib Therapy for Philadelphia Chromosome Positive Leukemia.

Dong Hwan Kim, MD, PhD, Suzanne Kamel-Reid, PhD, FACMG, Hong Chang, MD, Robert Sutherland, Ph.D., Chul Won Jung, M.D./Ph.D., Hyeoung Joon Kim, MD, Je-Jung Lee, MD, PhD, Jeffrey H. Lipton, MD, PhD

Blood (2008) 112 (11): 933.

https://doi.org/10.1182/blood.V112.11.933.933

Published: 2008

NARROW

Real-World Effectiveness and Safety of Eltrombopag in Patients with Aplastic Anemia: A Chinese Nationwide Survey

Downregulation of MDM2 Leads to Anti-Proliferative Effects through Activation of p53-Associated Pathway Mediated By Both Dual Inhibitor MX69 and Mir-548c-3p in Multiple Myeloma

Efficacy Analysis of Ruxolitinib in Treatment of 72 Patients with Myelofibrosis in a Chinese Institution

Overexpression of Mir-21-5p Induces Apoptosis and Cell Cycle Arrest By Down-Regulating SKP2 and Overcomes Bortezomib Resistance in Multiple Myeloma

Targeting CD47 and TNFAIP8 By Mir-155 Overcomes Drug Resistance and Inhibits Tumor Growth through Induction of Phagocytosis and Apoptosis in Multiple Myeloma

Marcks Inhibition By a Peptide Inhibitor, MPS, Cooperates with Bortezomib to Effectively Eliminate Drug Resistance in Multiple Myeloma

Targeting of Marcks By MiR-34a Overcomes Drug Resistance in Multiple Myeloma

Inhibition of the Epigenetic Modifier EZH2 By Mir-138 Upregulates Tumor Suppressor Gene Rbpms and Contributes to Drug Susceptibility in Preclinical Model of Multiple Myeloma

Restoration of Mir-138 Expression By Epigenetic Modulation Overcomes Drug Resistance in Multiple Myeloma Cells

Marcks Peptide Inhibitor Displays Synergistic Cytotoxicity with Bortezomib in Drug Resistant Multiple Myeloma Cells but Enhances Autophagic Effect

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

IKZF1/3 Protein Expressions Are Associated with a Better Survival in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide

Prima-1 Met Combined with Bortezomib Has Synergistic Anti-Myeloma Activity By Modulation of Apoptosis and Cell Cycle Regulating Genes

Bone Marrow Stromal Cells Induce Bortezomib Resistance in Multiple Myeloma Cells through Downregulation of miRNA-101-3p Targeting Survivin

Decitabine Combined With Chemotherapy For The Treatment Of Refractory Acute Myeloid Leukemia: a Pilot Phase 1 Clinical Study

Combination Imatinib with Interferon-α For Philadelphia Positive Acute Lymphocytic Leukemia: A Mutiple Centers Study In China

Imatinib 400mg Daily Combined with Vindesine and Dexamethasone As Induction and Maintenance Therapy for Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Experience with Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Study of 56 Patients in a Single Institute of China

Association of Interferon-Gamma +874(T/A) Single Nucleotide Polymorphism with Response to Immunosuppressive Therapy In Patients with Severe Aplastic Anemia.

Natural Killer (NK) or NK/T Cell Lineage Large Granular Lymphocytosis Associated with Dasatinib Therapy for Philadelphia Chromosome Positive Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only